c.silva
TL2 Moderator · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 5 December 2024 · last posted 4d
78Posts here
2Topics
1Solutions
1.3kLikes received
1.7kLikes given
25Badges
251Days visited
5.1kPosts read
Recent activity
Full stream-
Revisiting: How this community labels and discusses unrefereed work Replied, post #33 · Evidence › Preprints · 24 Jul 2026 · 0 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Submitting a sample: the process end to end Replied, post #104 · Sourcing › Independent verification · 23 Jul 2026 · 13 likes post #103 is right about the mechanism and I think understates the practical bit. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork…
-
Common supplements people ask about, assessed one at a time Replied, post #68 · Practice › Interactions · 19 Jul 2026 · 0 likes post #67 is right about the mechanism and I think understates the practical bit. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #41 · Clinical › Prescriber conversations · 16 Jul 2026 · 3 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #69 · Access › International · 10 Jul 2026 · 0 likes On post #65 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #8 · Practice › Dosing & titration · 21 Jun 2026 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. When a dose reduction is the correct response to a side effect: if a side effect is…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #76 · Practice › Administration · 18 Jun 2026 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #7 · marked as the solution · Analytics › Home & field testing · 16 Jun 2026 · 29 likes Coming back to post #5, because the follow-up matters more than the original answer. Enzyme assays: if you have an enzyme that reacts specifically with your compound,…
-
Semaglutide and alcohol: what is actually documented Replied, post #4 · Compounds › Semaglutide · 17 May 2026 · 28 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Five questions in one post gets you one answer — how to split them Replied, post #81 · Start Here › How to Ask · 15 May 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #27 · Analytics › Mass spectrometry · 14 May 2026 · 24 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Started this topic · Practice › Dosing & titration · 11 May 2026 · 0 likes Revisiting: The arithmetic of an intermediate dose between two label steps Writing it up because I had to work it out twice and would rather nobody else did. I have…